Skip to content
Open access

Effects of Single and Multiple Dose Tiotropium/Olodaterol in Chronic Obstructive Pulmonary Disease on Alveolar Gas Exchange Measured by Hyperpolarized 129Xe MRI.

Sep 2026 · Journal of Magnetic Resonance Imaging · 1 citation · 28 references
Medicine

TL;DR

Single-dose TIO/OLO increased 129Xe in RBC-Gas and septal thickness but not RBC-M, and multiple-dose treatment significantly increased RBC-Gas, M-Gas and M T2* compared with single-dose treatment, but not RBC-M.

Abstract

Background

Long-acting muscarinic antagonists/long-acting beta adrenoreceptor agonists lead to lung deflation and improved microvascular perfusion in hyperinflated chronic obstructive pulmonary disease (COPD), but with an unclear time course.

Purpose

To investigate the effect of inhalation of tiotropium/olodaterol (TIO/OLO) on MRI measures of gas uptake and microvascular blood volume after single and multiple doses. STUDY TYPE Prospective, randomized, investigator-blinded, placebo-controlled single-dose crossover study with open-label multiple-dose extension. POPULATION 31 participants with COPD and lung hyperinflation (residual volume > 135% predicted, ≥ 10 pack-years smoking). FIELDSTRENGTH/SEQUENCE 1.5 T/Interleaved 3D radial gas and dissolved-phase MRI using multi-echo FLASH, high-resolution spectroscopy, chemical shift saturation recovery spectroscopy. ASSESSMENT Ratios of 129Xe in membrane tissues (M) to gas (M-Gas), red blood cells (RBC) to gas (RBC-Gas), RBC to M (RBC-M) were calculated from dissolved-phase imaging. Dissolved-phase apparent transverse relaxation times (T2*) from high-resolution spectra were also calculated, and septal wall thickness and surface-volume ratio (S/V) were assessed by fitting a model of xenon exchange functions. Parameters were compared for single-dose (5 μg/5 μg TIO/OLO) versus placebo using saline, and single-dose versus multiple-dose (daily 5 μg/5 μg TIO/OLO for 14 days) treatments. STATISTICAL TESTS Linear mixed models with contrasts of estimated marginal means, significance level 0.05.

Results

Compared with placebo, single-dose treatment significantly increased RBC-Gas and septal thickness but not RBC-M (p = 0.06), M-Gas (p = 0.16), RBC T2* (p = 0.13), M T2* (p = 0.09) and S/V (p = 0.47). Multiple-dose treatment significantly increased RBC-Gas, M-Gas and M T2* compared with single-dose treatment, but not RBC-M (p = 0.82), RBC T2* (p = 0.48), septal thickness (p = 0.61), and S/V (p = 0.49). DATA

Conclusion

Single-dose TIO/OLO increased 129Xe in RBC-Gas. Multiple-dose treatment increased M-Gas and further increased RBC-Gas compared to single-dose treatment. TECHNICAL EFFICACY Stage 4. EVIDENCE LEVEL 2.

Read PDF

Similar papers

Open access Oct 2026

Assessing regional pulmonary response to methacholine and mannitol challenge in asthma patients using hyperpolarized helium-3 magnetic resonance imaging.

INTRODUCTION Ventilation heterogeneity is a feature of asthmatic bronchoconstriction and contributes to airway hyperresponsiveness and disease expression. This study characterized ventilation heterogeneity using hyperpolarized helium-3 magnetic resonance imaging (HP-MRI) in patients with mild asthma following methachol...

C. Foo, K. Nilsen, P. Noble et al. · 0 citations
Open access Oct 2026

Bronchodilator Drug Delivery With Pressurized Meter-Dose-Inhaler Versus Jet Nebulizer With Noninvasive-Ventilation in Acute-Exacerbation of COPD: A Randomized Controlled Pharmacokinetic Endpoint Trial.

BACKGROUND AND OBJECTIVE Non-invasive ventilation (NIV) and inhaled bronchodilator therapy are foundational in the management of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). However, optimal drug-delivery strategies during NIV remain uncertain. This study compared bronchodilator delivery via a...

Vishal Raj, P. K. Singh, Rama S. Akondy et al. · 0 citations

A study on effects of inhaled fluticasone propionate-salmeterol on pulmonary function in non-cystic fibrosis bronchiectasis patients

Background: Non-cystic fibrosis (CF) bronchiectasis is a chronic respiratory disease characterized by permanent dilatation of the airways. The patients usually suffer from chronic daily phlegm and breathlessness. Recurrent infections and exacerbations result in the decline of lung function and quality of life. Chronic...

Setthawuth Woraawarunsart · 0 citations
Open access Nov 2026

Acetazolamide-Induced Cerebral Vasoreactivity Assessed by Near Infrared Spectroscopy in COPD Patients-Prospective, Interventional, Non-Randomized Study

Background: Chronic obstructive pulmonary disease (COPD) is associated with affection of the cerebral vasculature, resulting in a higher incidence of stroke and cognitive decline. The exact pathophysiological background is not known, but among others, an altered function of the cerebral microvasculature is proposed as...

Regina Szabó-Szűcs, B. Fülesdi, Viktória Dudás et al. · 0 citations
Open access Oct 2026

Dapagliflozin in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: the DAPAH randomized controlled trial

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce mortality in left heart failure. In pre-capillary pulmonary hypertension (PH), preclinical data suggest SGLT2i may improve right ventricular (RV) function through metabolic modulation, reduced perivascular inflammation, and inhibition of vascular remodelin...

M. Ersbøll, J. Kjaergaard, F. Gustafsson et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.